Enhance Skin Products Inc. (fka EHSK)

[nickeli54]

The EHSK merger is with this company

http://www.integumenplc.com/investors/

They get all of EHSK's patents.

EHSK received 29.5M shares (approx) 14% of the company

Agreement already in place for $36M over the next 5 years.



This was announced last night-things starting to happen
https://relationshipscience.com/News/story/christopher-bell-is-now-serving-in-a-new-position--13453541

Completed the integration of the four acquired businesses and have continued to successfully commercialise the first series of products within skincare and oral care;
Launched TSPro’s brand in South Korea through a strategic supply agreement with Mono Dent, a leading distributor of oral hygiene products in South Korea;
Received orders from reputable blue chip clients with an ever-increasing focus on the human microbiome and R&D in skincare:
Conducted efficacy trials for La Prairie, a leading Swiss-based beauty company, which has been using Labskin, Integumen’s human skin equivalent model, as a platform to test certain materials in their product range;
Signed a Labskin evaluation order with Merck, an international developer, manufacturer and distributor of pharmaceuticals;
Recevied an order from Galderma, a pharmaceutical subsidiary specializing in the research, development and marketing of dermatological treatments, which is a wholly-owned subsidiary of Nestlé testing of materials and formulations in their HQ in Lausanne, Switzerland.

Received a Notice of Allowance (“NOA”) for the trademark “Clarogel” in the United States of America. Clarogel is an antimicrobial formulation of usnic acid which is a late stage product designed for blemish control;
Received NOA for Visible Youth patent in Canada, for the cosmetic composition for the treatment of skin. Visible Youth is a range of cosmeceuticals targeting the anti-ageing market;
Received a patent in the United States for the manufacture and sale of TS1, a tongue vacuum cleaner;
Signed a worldwide Patent Licence Agreement with Dr Gary Hack for his co-rights to various patents and know-how related to botulinum toxin (commonly known as Botox) treatments, dermal fillers and the “Botox Booster IP”.

Now waiting on offical/public announcement of a REVERSE TAKEOVER!!

Integumen proposes to acquire the entire issued and to be issued share capital of Cellulac.

Cellulac is at the forefront of the biodegradable plastic revolution. Integumen’s existing personal care business products offer “direct to consumer” access, transforming single-use plastic packaging to Cellulac’s biodegradable green solution.

*On completion, it is proposed that Integumen will change its name to Cellulac plc and that the shares in enlarged group will be admitted to trading on AIM.

8 million tonnes of plastic are dumped into the seas every year.
By 2050 the weight of plastic will equal the weight of the fish left in the oceans.
Government minds are focused on finding a solution because China has refused to take any more of the world’s rubbish since 2017.
Until recently Ireland shipped 95% of its plastics to China.
Britain’s plastic recycling has dropped because China won’t take it anymore.


Cellulac is owned by investors including Gerard Brandon, once the chief executive of Irish wound-care firm Alltracel.
Integumen’s non-executive chairman is Tony Richardson, previously a CEO of Alltracel.

Upon completion of the deal, which will constitute a reverse takeover, Mr Brandon will become chief executive of Integumen, whose name will be changed to Cellulac